Literature DB >> 7049672

Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat.

D P Loven, H P Schedl, L W Oberley, H D Wilson, L Bruch, C L Niehaus.   

Abstract

Insulin stimulates the production of superoxide and hydrogen peroxide in various tissues. Hydrogen peroxide has been proposed to be an intracellular second messenger for insulin and a moderator of cellular proliferation and differentiation. We previously found that cell proliferation is increased in small intestinal mucosa of streptozotocin-diabetic rats. The current study was undertaken to determine if superoxide dismutase (SOD), the enzyme that converts superoxide to hydrogen peroxide, is altered in the mucosa of the alimentary tract and renal cortex of the diabetic rat, and if so, whether SOD responds to insulin treatment. Total SOD and cyanide-insensitive [manganese-containing SOD (Mn SOD)] SOD were measured by the nitroblue tetrazolium inhibition assay. We studied ad libitum fed animals, where diabetics are hyperphagic and pair-fed animals, where hyperphagia is not present. Since cyclic nucleotides appear to control cell proliferation in some tissues, we also measured cAMP and cGMP in mucosa of the small intestine. In ad libitum fed animals, total SOD was depressed in the mucosa of duodenum, jejunum, and ileum, but not in the cecum or colon of the streptozotocin-diabetic rats. The level of Mn-SOD was not affected by diabetes or insulin treatment, but the cyanide-sensitive [copper- and zinc containing SOD (Cu-Zn SOD] SOD was depressed in the small intestine and colon of diabetic rats. Insulin treatment restored total and Cu-Zn SOD activity in the small intestine to normal and increased Cu-Zn SOD activity in the colon to normal. Pair-fed animals showed the same changes in the SOD activity of jejunal mucosa that were found in ad libitum fed animals. In renal cortex, diabetes did not alter total SOD, but increased Mn SOD and decreased Cu-Zn SOD. Both responses were reversed by insulin treatment. Cyclic nucleotide concentrations were not affected by diabetes. We conclude that SOD enzymes re altered in diabetes, at least in proliferating tissues. Responses are tissue specific. The mucosa of the small intestine and colon show decreased Cu-Zn SOD, the SOD of the cecum is unaffected, and the kidney shows increased Mn SOD and decreased Cu-Zn SOD. The SOD responses of diabetics are reversed by insulin treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049672     DOI: 10.1210/endo-111-3-737

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes.

Authors:  K Kamata; T Kobayashi
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Kidney glomerular explants in serum-free media: demonstration of intracellular antioxidant enzymes and active oxygen metabolites.

Authors:  B W Steinert; P J Anderson; L W Oberley; T D Oberley
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

3.  Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats.

Authors:  Pallavi V Limaye; Nandula Raghuram; S Sivakami
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

4.  The immunocytochemical localization of superoxide dismutase in the enterocytes of the avian intestine: the effect of vitamin D3.

Authors:  W L Davis; J L Matthews; K Shibata; M Kipnis; G R Farmer; E Cortinas; J C Meiyr; D B Goodman
Journal:  Histochem J       Date:  1989-04

5.  Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats.

Authors:  Noriyasu Kanie; Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

6.  The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats.

Authors:  I Staprans; J H Rapp; X M Pan; K R Feingold
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.